Ignite Creation Date:
2025-12-25 @ 4:32 AM
Ignite Modification Date:
2026-05-07 @ 6:10 AM
Study NCT ID:
NCT01656018
Status:
COMPLETED
Last Update Posted:
2016-04-07
First Post:
2012-07-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate Safety, Acceptability, Pharmacokinetics, and ex Vivo Pharmacodynamics of TMC278 Long Acting Formulation in HIV-1 Seronegative Participants
Sponsor:
Janssen Research & Development, LLC
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Healthy | View |